Literature DB >> 17709703

Frontal presentation in progressive supranuclear palsy.

L Donker Kaat1, A J W Boon, W Kamphorst, R Ravid, H J Duivenvoorden, J C van Swieten.   

Abstract

BACKGROUND: Progressive supranuclear palsy (PSP) is a progressive hypokinetic rigid disorder with supranuclear gaze palsy and frequent falls. Although clinical consensus criteria are available, an atypical presentation may lead to clinical misdiagnosis in the initial phase. In the present study we investigated the clinical presentation of PSP and its relationship to initial clinical diagnosis and survival.
METHODS: We ascertained patients with PSP in a prospective cohort by nationwide referral from neurologists and nursing home physicians. All patients underwent a structural interview and clinical examination before entering the study. Medical records were reviewed for the presence of symptoms during the first 2 years.
RESULTS: A total of 152 patients ascertained between 2002 and 2005 fulfilled the international consensus criteria for PSP. Categorical principal component analysis of clinical symptoms within the first 2 years showed apart from a cluster of typical PSP symptoms, the clustering of cognitive dysfunction and behavioral changes. Further analysis showed that 20% of patients had a predominant frontal presentation with less than two other PSP symptoms. Survival analysis showed that this subgroup had a similar prognosis to that of the total group of patients with PSP.
CONCLUSIONS: There exists a subgroup of patients with progressive supranuclear palsy (PSP) with a predominant frontal presentation, who progressed into typical PSP over the course of the disease.

Entities:  

Mesh:

Year:  2007        PMID: 17709703     DOI: 10.1212/01.wnl.0000267643.24870.26

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  46 in total

1.  Stereotypic behaviors in degenerative dementias.

Authors:  S Prioni; V Fetoni; F Barocco; V Redaelli; C Falcone; P Soliveri; F Tagliavini; A Scaglioni; P Caffarra; L Concari; S Gardini; F Girotti
Journal:  J Neurol       Date:  2012-05-31       Impact factor: 4.849

2.  LRP10 variants in progressive supranuclear palsy.

Authors:  Leonie J M Vergouw; Shamiram Melhem; Laura Donker Kaat; Wang Z Chiu; Demy J S Kuipers; Guido Breedveld; Agnita J W Boon; Li-San Wang; Adam C Naj; Elizabeth Mlynarksi; Laura Cantwell; Marialuisa Quadri; Owen A Ross; Dennis W Dickson; Gerard D Schellenberg; John C van Swieten; Vincenzo Bonifati; Frank Jan de Jong
Journal:  Neurobiol Aging       Date:  2020-04-30       Impact factor: 4.673

3.  Magnetic resonance imaging in progressive supranuclear palsy.

Authors:  M Stamelou; S Knake; W H Oertel; G U Höglinger
Journal:  J Neurol       Date:  2010-12-22       Impact factor: 4.849

4.  Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia.

Authors:  Christopher Kobylecki; Matthew Jones; Jennifer C Thompson; Anna M Richardson; David Neary; David M A Mann; Julie S Snowden; Alexander Gerhard
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

Review 5.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

6.  Evolution of oculomotor and clinical findings in autopsy-proven Richardson syndrome.

Authors:  A Hardwick; J C Rucker; M L Cohen; R P Friedland; K Gustaw-Rothenberg; D E Riley; R J Leigh
Journal:  Neurology       Date:  2009-12-15       Impact factor: 9.910

7.  In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.

Authors:  Karin Srulijes; Grit Mallien; Sarah Bauer; Elisabeth Dietzel; Adriane Gröger; Georg Ebersbach; Daniela Berg; Walter Maetzler
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

8.  Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium.

Authors:  Toji Miyagawa; Danielle Brushaber; Jeremy Syrjanen; Walter Kremers; Julie Fields; Leah K Forsberg; Hilary W Heuer; David Knopman; John Kornak; Adam Boxer; Howie Rosen; Bradley Boeve
Journal:  Alzheimers Dement       Date:  2020-01-06       Impact factor: 21.566

9.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.

Authors:  Han Soo Yoo; Seok Jong Chung; Soo-Jong Kim; Jung Su Oh; Jae Seung Kim; Byoung Seok Ye; Young Ho Sohn; Phil Hyu Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.